This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Obach, V. Articles by Chamorro, A. Search for Related Content PubMed PubMed Citation Articles by Obach, V. Articles by Chamorro, A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Stroke Related Collections Genetics of Stroke Risk Factors for Stroke

(Stroke. 2001;32:2588.)
© 2001 American Heart Association, Inc.

Original Contributions

₁-Antichymotrypsin Polymorphism

A Risk Factor for Hemorrhagic Stroke in Normotensive Subjects

Víctor Obach, MD; Marián Revilla, MD; Nicolás Vila, MD; Álvaro Cervera, MD Ángel Chamorro, MD, PhD

From the Neurology Service, Institut d’Investigació Biomedica August Pi i Sunyer (IDIBAPS) Hospital Clínic, Barcelona, Spain.

Correspondence to Ángel Chamorro, MD, Neurology Service, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. E-mail chamorro{at}medicina.ub.es

Background and Purpose—— Although genetic factors may be important in the pathogenesis of ischemic stroke (IS), little is known on the potential role of genes in most cases of hemorrhagic stroke (HS). Preliminary data showed that the TT genotype of the ₁-antichymotrypsin (ACT) gene polymorphism was associated with HS, although it remained unsettled whether prevalence of this polymorphism might differ between hypertensive and normotensive HS.

Methods—— Ninety-nine patients with HS, 182 patients with IS (symptomatic control subjects), and 80 asymptomatic control subjects were genotyped for the ACT polymorphism using polymerase chain reaction amplification. Chronic hypertension was recorded in 66 patients with HS.

Results—— The ACT-TT genotype was more prevalent in patients than in asymptomatic or symptomatic control subjects: 26%, 15%, and 16%, respectively. The ACT-TT genotype was obtained in 33% of HS who lacked arterial hypertension (P<0.05). After adjustment for age, gender, and vascular risk factors, the ACT-TT genotype remained independently associated with HS (OR 2.80, 95% CI 1.19 to 6.58, compared with asymptomatic control subjects; OR 1.79, 95% CI 0.95 to 3.40, compared with symptomatic control subjects). In analyses restricted to HS in normotensive patients, the ORs were 3.10 (95% CI 1.10 to 8.68) and 2.53 (95% CI 1.04 to 6.18), respectively.

Conclusions—— These findings confirm in a larger series of patients the association between the ACT-TT genotype and HS. This polymorphism is more prevalent in normotensive bleedings. Pathological studies will be required to establish whether the ACT-TT genotype facilitates proteolytic rupture of vessels that harbor amyloidotic changes or another form of nonhypertensive cerebral angiopathy.

Key Words: ₁-antichymotrypsin • cerebral hemorrhage • cerebral amyloid angiopathy • genetics • stroke

This article has been cited by other articles:

				J. Pera, A. Slowik, T. Dziedzic, and A. Szczudlik SERPINA3 Polymorphism Is Not Associated With Primary Intracerebral Hemorrhage in a Polish Population Stroke, March 1, 2006; 37(3): 906 - 907. [Abstract] [Full Text] [PDF]